Expression was significantly increased in mice in the BS group compared to mice in the BC group (VEGF: 2.5-fold increase, P = 0.0014; CD31: 2.1-fold increase, P = 0.0004; MMP9: 2.2-fold increase, P = 0.0028). Here, PECAM1 is linked to breast cancer.